Technology
Health
Biotechnology

Blueprint Medicines

$99.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$2.05 (2.10%) Today
$0.00 (0.00%) As of 4:06 PM EDT after-hours

Why Robinhood?

You can buy or sell BPMC and other stocks, options, ETFs, and crypto commission-free!

About BPMC

Blueprint Medicines Corporation Common Stock, also called Blueprint Medicines, is a precision therapy company, which focuses on medicines to improve the lives of patients with genomically defined cancers, rare diseases and cancer immunotherapy. The company was founded by Chris Varma, Nicholas B. Read More Lydon, Brian Druker, and Alexis Borisy in October 2008 and is headquartered in Cambridge, MA.

Employees
217
Headquarters
Cambridge, Massachusetts
Founded
2008
Market Cap
4.32B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
305.54K
High Today
$101.24
Low Today
$97.39
Open Price
$97.39
Volume
374.63K
52 Week High
$101.91
52 Week Low
$44.58

Collections

Technology
Health
Biotechnology
2015 IPO
US
North America

BPMC Earnings

-$1.98
-$1.53
-$1.07
-$0.62
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Jul 31, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.